{"DataElement":{"publicId":"7615598","version":"1","preferredName":"Negation Infectious Disorder Pulmonary Abnormality Occurrence Organ Impairment And/Or Disease or Disorder Type","preferredDefinition":"A description of the other non-infectious pulmonary abnormality.","longName":"2795875v1.0:2797322v2.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2795875","version":"1","preferredName":"Negation Infectious Disorder Pulmonary Abnormality Occurrence","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction._A disorder resulting from the presence and activity of a microbial, viral, or parasitic agent. It can be transmitted by direct or indirect contact. -- 2003._Relating to the lungs._A condition that differs from the usual physical or mental state._An instance of something happening, such as an event or incident.","longName":"NEG_ID_PULM_ABN_OC","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2960981","version":"1","preferredName":"Negation Infection Pulmonary Abnormality","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction.:A disorder resulting from the presence and activity of a microbial, viral, or parasitic agent. It can be transmitted by direct or indirect contact. -- 2003:Relating to the lungs.:A condition that differs from the usual physical or mental state.","longName":"C25594:C26726:C13304:C9440","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Infectious Disorder","conceptCode":"C26726","definition":"A disorder resulting from the presence and activity of a microbial, viral, fungal, or parasitic agent. It can be transmitted by direct or indirect contact.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Pulmonary","conceptCode":"C13304","definition":"Relating to the lungs as the intended site of administration, where the pharmaceutical product is administered, usually by inhalation, for local action in the lower respiratory tract or for systemic action after absorption via the lower respiratory tract.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Abnormality","conceptCode":"C9440","definition":"A condition that differs from the usual physical or mental state.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7897AE8B-394D-EAE1-E040-BB89AD432941","latestVersionIndicator":"Yes","beginDate":"2009-11-17","endDate":null,"createdBy":"NYCHM","dateCreated":"2009-11-17","modifiedBy":"ONEDATA","dateModified":"2009-11-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2234856","version":"1","preferredName":"Occurrence","preferredDefinition":"Occurrence; an instance of something happening.","longName":"C25275","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Occurrence","conceptCode":"C25275","definition":"An instance of something happening, such as an event or incident.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9860F29-72B8-7421-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-14","modifiedBy":"ONEDATA","dateModified":"2005-06-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5A671961-B5C1-1D28-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-10-29","endDate":null,"createdBy":"LEEB","dateCreated":"2008-10-29","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2797322","version":"2","preferredName":"Organ Impairment And/Or Disease or Disorder Type","preferredDefinition":"A unique macroscopic (gross) anatomic structure that performs specific functions.  It is composed of various tissues.  An organ is part of an anatomic system or a body region.  Representative examples include the heart, lung, liver, spleen, and uterus._Loss or abnormality of psychological, physiological, or anatomic structure or function._Used to indicate that either or both of two items or options may be valid._Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._Something distinguishable as an identifiable class based on common qualities.","longName":"2797322v2.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"150","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Growth hormone deficiency / short stature","valueDescription":"Growth Hormone Deficiency And/Or Short Stature","ValueMeaning":{"publicId":"5127612","version":"1","preferredName":"Growth Hormone Deficiency And/Or Short Stature","longName":"5127612","preferredDefinition":"Insufficient production of growth hormone.: Used to indicate that either or both of two items or options may be valid.: Height greater than two standard deviations below the mean of the appropriate reference population for the age and sex of the individual.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Growth Hormone Deficiency","conceptCode":"C112835","definition":"Insufficient production of growth hormone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"And/Or","conceptCode":"C48928","definition":"Used to indicate that either or both of two items or options may be valid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Short Stature","conceptCode":"C118686","definition":"Height greater than two standard deviations below the mean of the appropriate reference population for the age and sex of the individual.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2C6225A9-D774-90B7-E050-BB89AD432E5A","latestVersionIndicator":"Yes","beginDate":"2016-02-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2C6225A9-D78D-90B7-E050-BB89AD432E5A","beginDate":"2016-02-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-22","modifiedBy":"ONEDATA","dateModified":"2016-02-22","deletedIndicator":"No"},{"value":"Diabetes / hyperglycemia requiring chronic treatment","valueDescription":"Diabetes Mellitus And/Or Hyperglycemia Requirement Chronic Therapeutic Procedure","ValueMeaning":{"publicId":"5127613","version":"1","preferredName":"Diabetes Mellitus And/Or Hyperglycemia Requirement Chronic Therapeutic Procedure","longName":"5127613","preferredDefinition":"A metabolic disorder characterized by abnormally high blood sugar levels due to diminished production of insulin or insulin resistance/desensitization.: Used to indicate that either or both of two items or options may be valid.: Abnormally high level of glucose in the blood.: Something that is a necessary condition; something that is obligatory.: Usually used to describe a condition that is persistent and long standing.: An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diabetes Mellitus","conceptCode":"C2985","definition":"A metabolic disorder characterized by abnormally high blood sugar levels due to diminished production of insulin or insulin resistance/desensitization.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"And/Or","conceptCode":"C48928","definition":"Used to indicate that either or both of two items or options may be valid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Hyperglycemia","conceptCode":"C26797","definition":"Abnormally high level of glucose in the blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Requirement","conceptCode":"C25652","definition":"Something that is a necessary condition; something that is obligatory.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Chronic","conceptCode":"C14141","definition":"Usually used to describe a condition that is persistent and long standing.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2C6225A9-D79E-90B7-E050-BB89AD432E5A","latestVersionIndicator":"Yes","beginDate":"2016-02-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2C6225A9-D7B7-90B7-E050-BB89AD432E5A","beginDate":"2016-02-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-22","modifiedBy":"ONEDATA","dateModified":"2016-02-22","deletedIndicator":"No"},{"value":"Hypothyroidism requiring replacement therapy","valueDescription":"Hypothyroidism Requirement Replacement Therapy","ValueMeaning":{"publicId":"5127614","version":"1","preferredName":"Hypothyroidism Requirement Replacement Therapy","longName":"5127614","preferredDefinition":"Abnormally low levels of thyroid hormone.: Something that is a necessary condition; something that is obligatory.: Administration of a body substance to compensate for the loss, as from disease or surgery, of a gland or tissue that would normally produce the substance.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hypothyroidism","conceptCode":"C26800","definition":"Abnormally low levels of thyroid hormone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Requirement","conceptCode":"C25652","definition":"Something that is a necessary condition; something that is obligatory.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Replacement Therapy","conceptCode":"C15471","definition":"Administration of a body substance to compensate for the loss, as from disease or surgery, of a gland or tissue that would normally produce the substance.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2C6225A9-D7C6-90B7-E050-BB89AD432E5A","latestVersionIndicator":"Yes","beginDate":"2016-02-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2C6225A9-D7DF-90B7-E050-BB89AD432E5A","beginDate":"2016-02-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-22","modifiedBy":"ONEDATA","dateModified":"2016-02-22","deletedIndicator":"No"},{"value":"Hemorrhagic cystitis / hematuria requiring medical intervention","valueDescription":"Hemorrhagic Cystitis And/Or Hematuria Requirement Medical Intervention or Procedure","ValueMeaning":{"publicId":"5073080","version":"1","preferredName":"Hemorrhagic Cystitis And/Or Hematuria Requirement Medical Intervention or Procedure","longName":"5073080","preferredDefinition":"Inflammation of the bladder resulting in bloody urine.: Used to indicate that either or both of two items or options may be valid.: Blood in the urine.: Something that is a necessary condition; something that is obligatory.: Relating to the study or practice of medicine.: An activity that produces an effect, or that is intended to alter the course of a disease in a patient or population. This is a general term that encompasses the medical, social, behavioral, and environmental acts that can have preventive, therapeutic, or palliative effects.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemorrhagic Cystitis","conceptCode":"C114666","definition":"Inflammation of the bladder resulting in bloody urine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"And/Or","conceptCode":"C48928","definition":"Used to indicate that either or both of two items or options may be valid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Hematuria","conceptCode":"C3090","definition":"Blood in the urine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Requirement","conceptCode":"C25652","definition":"Something that is a necessary condition; something that is obligatory.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Medical","conceptCode":"C25261","definition":"Relating to the study or practice of medicine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Intervention or Procedure","conceptCode":"C25218","definition":"An activity that produces an effect, or that is intended to alter the course of a disease in a patient or population. This is a general term that encompasses the medical, social, behavioral, and environmental acts that can have preventive, therapeutic, or palliative effects.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"26168627-0232-F3EC-E050-BB89AD430565","latestVersionIndicator":"Yes","beginDate":"2015-12-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-12-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2CB1C481-C438-1475-E050-BB89AD433B19","beginDate":"2015-12-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-26","modifiedBy":"ONEDATA","dateModified":"2016-02-26","deletedIndicator":"No"},{"value":"Gonadal dysfunction requiring hormone replacement","valueDescription":"Gonadal Disorder Requirement Hormone Replacement Therapy","ValueMeaning":{"publicId":"5127615","version":"1","preferredName":"Gonadal Disorder Requirement Hormone Replacement Therapy","longName":"5127615","preferredDefinition":"Disease of the ovaries and testes of any etiology.: Something that is a necessary condition; something that is obligatory.: Treatment with estrogens or estrogen/progesterone after menopause or ovariectomy to prevent pathological effects of decreased estrogen production.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gonadal Disorder","conceptCode":"C26786","definition":"A non-neoplastic or neoplastic disorder that affects the testis or the ovary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Requirement","conceptCode":"C25652","definition":"Something that is a necessary condition; something that is obligatory.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Hormone Replacement Therapy","conceptCode":"C15599","definition":"Treatment with estrogens or estrogen/progesterone after menopause or ovariectomy to prevent pathological effects of decreased estrogen production.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2C6243D1-5F5B-6280-E050-BB89AD4367B8","latestVersionIndicator":"Yes","beginDate":"2016-02-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2C6243D1-5F74-6280-E050-BB89AD4367B8","beginDate":"2016-02-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-22","modifiedBy":"ONEDATA","dateModified":"2016-02-22","deletedIndicator":"No"},{"value":"Mucositis requiring therapy","valueDescription":"Mucositis Requirement Therapeutic Procedure","ValueMeaning":{"publicId":"5127632","version":"1","preferredName":"Mucositis Requirement Therapeutic Procedure","longName":"5127632","preferredDefinition":"Inflammation of the mucous membranes.: Something that is a necessary condition; something that is obligatory.: An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mucositis","conceptCode":"C115965","definition":"Inflammation of the mucous membranes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Requirement","conceptCode":"C25652","definition":"Something that is a necessary condition; something that is obligatory.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2C6243D1-5F84-6280-E050-BB89AD4367B8","latestVersionIndicator":"Yes","beginDate":"2016-02-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2C6243D1-5F9D-6280-E050-BB89AD4367B8","beginDate":"2016-02-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-22","modifiedBy":"ONEDATA","dateModified":"2016-02-22","deletedIndicator":"No"},{"value":"Iron overload requiring therapy","valueDescription":"Iron Overload Requirement Therapeutic Procedure","ValueMeaning":{"publicId":"5127633","version":"1","preferredName":"Iron Overload Requirement Therapeutic Procedure","longName":"5127633","preferredDefinition":"Accumulation of iron in the tissues. It may be a manifestation of an inherited disorder (e.g., hemochromatosis) or acquired (in patients with repeated blood transfusions). Symptoms include hepatomegaly, arthritis, diabetes mellitus, and bronzed skin. If untreated it has a progressive course and may lead to death.: Something that is a necessary condition; something that is obligatory.: An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Iron Overload","conceptCode":"C78393","definition":"Accumulation of iron in the tissues. It may be a manifestation of an inherited disorder (e.g., hemochromatosis) or acquired (in patients with repeated blood transfusions). Symptoms include hepatomegaly, arthritis, diabetes mellitus, and bronzed skin. If untreated it has a progressive course and may lead to death.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Requirement","conceptCode":"C25652","definition":"Something that is a necessary condition; something that is obligatory.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2C6243D1-5FAB-6280-E050-BB89AD4367B8","latestVersionIndicator":"Yes","beginDate":"2016-02-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2C6243D1-5FC4-6280-E050-BB89AD4367B8","beginDate":"2016-02-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-22","modifiedBy":"ONEDATA","dateModified":"2016-02-22","deletedIndicator":"No"},{"value":"Hyperlipidemia requiring therapy","valueDescription":"Hyperlipidemia Requirement Therapeutic Procedure","ValueMeaning":{"publicId":"5127634","version":"1","preferredName":"Hyperlipidemia Requirement Therapeutic Procedure","longName":"5127634","preferredDefinition":"An excess of lipids in the blood.: Something that is a necessary condition; something that is obligatory.: An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hyperlipidemia","conceptCode":"C34707","definition":"Elevated levels of lipids in the blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Requirement","conceptCode":"C25652","definition":"Something that is a necessary condition; something that is obligatory.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2C6243D1-5FD2-6280-E050-BB89AD4367B8","latestVersionIndicator":"Yes","beginDate":"2016-02-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2C6243D1-5FEB-6280-E050-BB89AD4367B8","beginDate":"2016-02-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-22","modifiedBy":"ONEDATA","dateModified":"2016-02-22","deletedIndicator":"No"},{"value":"Osteoporotic fracture","valueDescription":"Osteoporotic Fracture","ValueMeaning":{"publicId":"5127636","version":"1","preferredName":"Osteoporotic Fracture","longName":"5127636","preferredDefinition":"A pathologic bone fracture due to osteoporosis. It is generally caused by a fall from a standing height or lower and usually involves the spine, hip, or wrist.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Osteoporotic Fracture","conceptCode":"C80097","definition":"A pathologic bone fracture due to osteoporosis. It is generally caused by a fall from a standing height or lower and usually involves the spine, hip, or wrist.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2C6243D1-5FF8-6280-E050-BB89AD4367B8","latestVersionIndicator":"Yes","beginDate":"2016-02-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2C6243D1-6011-6280-E050-BB89AD4367B8","beginDate":"2016-02-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-22","modifiedBy":"ONEDATA","dateModified":"2016-02-22","deletedIndicator":"No"},{"value":"Osteonecrosis of the jaw","valueDescription":"Osteonecrosis of Jaw","ValueMeaning":{"publicId":"2945847","version":"1","preferredName":"Osteonecrosis of Jaw","longName":"2945847","preferredDefinition":"An area of necrotic bone in the mandible or maxilla.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Osteonecrosis of Jaw","conceptCode":"C63924","definition":"An area of necrotic bone in the mandible or maxilla.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74597246-163B-6D19-E040-BB89AD431E08","latestVersionIndicator":"Yes","beginDate":"2009-09-24","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2C6243D1-6025-6280-E050-BB89AD4367B8","beginDate":"2016-02-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-22","modifiedBy":"ONEDATA","dateModified":"2016-02-22","deletedIndicator":"No"},{"value":"Liver / hepatic iron concentration","valueDescription":"Liver Iron Concentration","ValueMeaning":{"publicId":"5039943","version":"1","preferredName":"Liver Iron Concentration","longName":"5039943","preferredDefinition":"A measurement of the concentration of iron in the liver as an estimate of body iron load.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Liver Iron Concentration","conceptCode":"C124065","definition":"A measurement of the concentration of iron in the liver as an estimate of body iron load.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"233E0BDB-0FDD-F629-E050-BB89AD4314D5","latestVersionIndicator":"Yes","beginDate":"2015-10-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-10-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2C612778-DA9F-0559-E050-BB89AD430531","beginDate":"2015-10-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-22","modifiedBy":"ONEDATA","dateModified":"2016-02-22","deletedIndicator":"No"},{"value":"Iron overload","valueDescription":"Hemochromatosis","ValueMeaning":{"publicId":"3171844","version":"1","preferredName":"Hemochromatosis","longName":"3171844","preferredDefinition":"An inherited metabolic disorder characterized by iron accumulation in the tissues.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hereditary Hemochromatosis","conceptCode":"C84481","definition":"An inherited metabolic disorder characterized by iron accumulation in the tissues.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"97DDA7EA-0192-07E7-E040-BB89AD4351C6","latestVersionIndicator":"Yes","beginDate":"2010-12-20","endDate":null,"createdBy":"WHITES","dateCreated":"2010-12-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2C612778-DAA9-0559-E050-BB89AD430531","beginDate":"2015-10-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-22","modifiedBy":"ONEDATA","dateModified":"2016-02-22","deletedIndicator":"No"},{"value":"Other impairment or disorder","valueDescription":"Other Impairment Or Disease or Disorder","ValueMeaning":{"publicId":"4733389","version":"1","preferredName":"Other Impairment Or Disease or Disorder","longName":"4733389","preferredDefinition":"Different than the one(s) previously specified or mentioned.: Loss or abnormality of psychological, physiological, or anatomic structure or function.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Impairment","conceptCode":"C21055","definition":"Loss or abnormality of psychological, physiological, or anatomic structure or function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"107C903E-52FA-B549-E050-BB89AD437D48","latestVersionIndicator":"Yes","beginDate":"2015-03-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-03-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2C612778-DAB3-0559-E050-BB89AD430531","beginDate":"2015-03-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-22","modifiedBy":"ONEDATA","dateModified":"2016-02-22","deletedIndicator":"No"},{"value":"Other non-infectious liver toxicity","valueDescription":"Other Negation Infectious Disorder Liver Toxicity","ValueMeaning":{"publicId":"4733391","version":"1","preferredName":"Other Negation Infectious Disorder Liver Toxicity","longName":"4733391","preferredDefinition":"Different than the one(s) previously specified or mentioned.: An operation in which a term denies or inverts the meaning of another term or construction.: A disorder resulting from the presence and activity of a microbial, viral, or parasitic agent. It can be transmitted by direct or indirect contact.: A triangular-shaped organ located under the diaphragm in the right hypochondrium.  It is the largest internal organ of the body, weighting up to 2 kg.  Metabolism and bile secretion are its main functions.  It is composed of cells which have the ability to regenerate.: The finding of bodily harm due to the poisonous effects of something.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Infectious Disorder","conceptCode":"C26726","definition":"A disorder resulting from the presence and activity of a microbial, viral, fungal, or parasitic agent. It can be transmitted by direct or indirect contact.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Liver","conceptCode":"C12392","definition":"A triangular-shaped organ located under the diaphragm in the right hypochondrium. It is the largest internal organ of the body, weighting up to 2 kg. Metabolism and bile secretion are its main functions. It is composed of cells which have the ability to regenerate.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Toxicity","conceptCode":"C27990","definition":"The finding of bodily harm due to the poisonous effects of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"107C903E-5330-B549-E050-BB89AD437D48","latestVersionIndicator":"Yes","beginDate":"2015-03-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-03-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2C612778-DABD-0559-E050-BB89AD430531","beginDate":"2015-03-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-22","modifiedBy":"ONEDATA","dateModified":"2016-02-22","deletedIndicator":"No"},{"value":"Congestive heart failure / Cardiomyopathy","valueDescription":"Congestive Heart Failure And/Or Cardiomyopathy","ValueMeaning":{"publicId":"4733392","version":"1","preferredName":"Congestive Heart Failure And/Or Cardiomyopathy","longName":"4733392","preferredDefinition":"Failure of the heart to pump a sufficient amount of blood to meet the needs of the body tissues, resulting in tissue congestion and edema. Signs and symptoms include shortness of breath, pitting edema, enlarged tender liver, engorged neck veins, and pulmonary rales.: Used to indicate that either or both of two items or options may be valid.: A disease of the heart muscle or myocardium proper. Cardiomyopathies may be classified as either primary or secondary, on the basis of etiology, or on the pathophysiology of the lesion: hypertrophic, dilated, or restrictive.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Congestive Heart Failure","conceptCode":"C3080","definition":"Failure of the heart to pump a sufficient amount of blood to meet the needs of the body tissues, resulting in tissue congestion and edema. Signs and symptoms include shortness of breath, pitting edema, enlarged tender liver, engorged neck veins, and pulmonary rales.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"And/Or","conceptCode":"C48928","definition":"Used to indicate that either or both of two items or options may be valid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Cardiomyopathy","conceptCode":"C34830","definition":"A disease of the heart muscle or myocardium proper. Cardiomyopathies may be classified as either primary or secondary, on the basis of etiology, or on the pathophysiology of the lesion: hypertrophic, dilated, or restrictive.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"107C903E-5357-B549-E050-BB89AD437D48","latestVersionIndicator":"Yes","beginDate":"2015-03-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-03-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2C612778-DAC7-0559-E050-BB89AD430531","beginDate":"2015-03-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-22","modifiedBy":"ONEDATA","dateModified":"2016-02-22","deletedIndicator":"No"},{"value":"Wounds requiring surgery","valueDescription":"Injury Requirement Surgery","ValueMeaning":{"publicId":"4733397","version":"1","preferredName":"Injury Requirement Surgery","longName":"4733397","preferredDefinition":"Damage inflicted on the body as the direct or indirect result of an external force, with or without disruption of structural continuity.: Something that is a necessary condition; something that is obligatory.: The branch of medical science that treats disease or injury by operative procedures.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Injury","conceptCode":"C3671","definition":"Damage inflicted on the body as the direct or indirect result of an external force, with or without disruption of structural continuity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Requirement","conceptCode":"C25652","definition":"Something that is a necessary condition; something that is obligatory.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Surgery","conceptCode":"C17173","definition":"The branch of medical science that treats disease or injury by operative procedures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"107C903E-53A1-B549-E050-BB89AD437D48","latestVersionIndicator":"Yes","beginDate":"2015-03-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-03-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2C612778-DADB-0559-E050-BB89AD430531","beginDate":"2015-03-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-22","modifiedBy":"ONEDATA","dateModified":"2016-02-22","deletedIndicator":"No"},{"value":"Avascular necrosis","valueDescription":"Avascular Necrosis","ValueMeaning":{"publicId":"4733331","version":"1","preferredName":"Avascular Necrosis","longName":"4733331","preferredDefinition":"Tissue death resulting from an interruption to the blood supply.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Avascular Necrosis","conceptCode":"C118385","definition":"Tissue death resulting from an interruption to the blood supply.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"107C4D77-22B7-10F2-E050-BB89AD437429","latestVersionIndicator":"Yes","beginDate":"2015-03-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-03-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2C612778-DAE5-0559-E050-BB89AD430531","beginDate":"2015-03-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-22","modifiedBy":"ONEDATA","dateModified":"2016-02-22","deletedIndicator":"No"},{"value":"Cataracts","valueDescription":"Cataract","ValueMeaning":{"publicId":"2797325","version":"1","preferredName":"Cataract","longName":"2797325","preferredDefinition":"Partial or complete opacity of the crystalline lens of one or both eyes that decreases visual acuity and eventually results in blindness.  Some cataracts appear in infancy or in childhood, but most develop in older individuals. (Diagnostic Surgical Pathology, 3rd ed.) --2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cataract","conceptCode":"C26713","definition":"Partial or complete opacity of the crystalline lens of one or both eyes that decreases visual acuity and eventually results in blindness. Some cataracts appear in infancy or in childhood, but most develop in older individuals. (Sternberg Diagnostic Surgical Pathology, 3rd ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5AD63DAD-D834-12B9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"COOPERM","dateCreated":"2008-11-03","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2C612778-DAF9-0559-E050-BB89AD430531","beginDate":"2008-11-03","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-22","modifiedBy":"ONEDATA","dateModified":"2016-02-22","deletedIndicator":"No"},{"value":"Pancreatitis","valueDescription":"Pancreatitis","ValueMeaning":{"publicId":"2797355","version":"1","preferredName":"Pancreatitis","longName":"2797355","preferredDefinition":"Inflammation of the pancreas. Chronic pancreatitis may cause diabetes and problems with digestion. Pain is the primary symptom.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatitis","conceptCode":"C3306","definition":"Inflammation of the pancreas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5AE136BB-D344-5C1C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"COOPERM","dateCreated":"2008-11-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2C612778-DB03-0559-E050-BB89AD430531","beginDate":"2008-11-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-22","modifiedBy":"ONEDATA","dateModified":"2016-02-22","deletedIndicator":"No"},{"value":"Hypothyroidism","valueDescription":"Hypothyroidism","ValueMeaning":{"publicId":"2562672","version":"1","preferredName":"Hypothyroidism","longName":"2562672","preferredDefinition":"A condition in which the production of thyroid hormone by the thyroid gland is diminished. Signs and symptoms of hypothyroidism include low metabolic rate, tendency to weight gain, somnolence and sometimes myxedema. In the United States, the most common cause of hypothyroidism is Hashimoto's thyroiditis, an autoimmune disorder. SYN athyrea. --2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hypothyroidism","conceptCode":"C26800","definition":"Abnormally low levels of thyroid hormone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C1DD-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-10-11","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-11","modifiedBy":"COOPERM","dateModified":"2008-11-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2C612778-DB0D-0559-E050-BB89AD430531","beginDate":"2008-11-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-22","modifiedBy":"ONEDATA","dateModified":"2016-02-22","deletedIndicator":"No"},{"value":"Bronchiolitis obliterans","valueDescription":"Bronchiolitis Obliterans","ValueMeaning":{"publicId":"2793851","version":"1","preferredName":"Bronchiolitis Obliterans","longName":"2793851","preferredDefinition":"Inflammation of the bronchioles with obstruction by fibrous granulation tissue or bronchial exudate. It may follow inhalation of irritating gases or foreign bodies and it complicates pneumonia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bronchiolitis Obliterans","conceptCode":"C62580","definition":"Inflammation of the bronchioles with obstruction by fibrous granulation tissue or bronchial exudate. It may follow inhalation of irritating gases or foreign bodies and it complicates pneumonia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"594ACCA7-61DB-720E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"LEATHERJ","dateCreated":"2008-10-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2C612778-DB17-0559-E050-BB89AD430531","beginDate":"2008-11-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-22","modifiedBy":"ONEDATA","dateModified":"2016-02-22","deletedIndicator":"No"},{"value":"Deep vein thrombosis (DVT) / Pulmonary embolism (PE)","valueDescription":"Deep Vein Thrombosis And/Or Pulmonary Embolism","ValueMeaning":{"publicId":"4733291","version":"1","preferredName":"Deep Vein Thrombosis And/Or Pulmonary Embolism","longName":"4733291","preferredDefinition":"A blood clot in a deep vein, predominantly in the lower extremity, but may include the pelvis or upper extremity.: Used to indicate that either or both of two items or options may be valid.: The obstruction of the pulmonary artery or one of its branches by an embolus, sometimes associated with infarction of the lung.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Deep Vein Thrombosis","conceptCode":"C49343","definition":"A blood clot in a deep vein, predominantly in the lower extremity, but may include the pelvis or upper extremity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"And/Or","conceptCode":"C48928","definition":"Used to indicate that either or both of two items or options may be valid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Pulmonary Embolism","conceptCode":"C50713","definition":"The obstruction of the pulmonary artery or one of its branches by an embolus, sometimes associated with infarction of the lung.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"107BC70C-A0BC-B0D0-E050-BB89AD432FE8","latestVersionIndicator":"Yes","beginDate":"2015-03-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-03-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2C612778-DB21-0559-E050-BB89AD430531","beginDate":"2015-03-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-22","modifiedBy":"ONEDATA","dateModified":"2016-02-22","deletedIndicator":"No"},{"value":"Myocardial infarction / Unstable angina","valueDescription":"Myocardial Infarction And/Or Unstable Angina","ValueMeaning":{"publicId":"4733292","version":"1","preferredName":"Myocardial Infarction And/Or Unstable Angina","longName":"4733292","preferredDefinition":"Gross necrosis of the myocardium, as a result of interruption of the blood supply to the area, as in coronary thrombosis.: Used to indicate that either or both of two items or options may be valid.: Angina pectoris (or equivalent type of ischemic discomfort) with any 1 of the 3 following features: a) Angina occurring at rest and prolonged, usually greater than 20 minutes; b) New onset angina of at least Canadian Cardiovascular Society Grading Scale (or CCS classification system) classification severity III or greater; c) Recent acceleration in angina accentuated by an increase in severity of at least 1 CCS class to at least CCS class III. The biomarkers of necrosis are below the threshold of myocardial infarction.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myocardial Infarction","conceptCode":"C27996","definition":"Gross necrosis of the myocardium, as a result of interruption of the blood supply to the area, as in coronary thrombosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"And/Or","conceptCode":"C48928","definition":"Used to indicate that either or both of two items or options may be valid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Unstable Angina","conceptCode":"C66911","definition":"Angina pectoris (or equivalent type of ischemic discomfort) which has recently changed in frequency, duration, intensity, or occurs at rest.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"107BC70C-A0E3-B0D0-E050-BB89AD432FE8","latestVersionIndicator":"Yes","beginDate":"2015-03-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-03-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2C612778-DB2B-0559-E050-BB89AD430531","beginDate":"2015-03-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-22","modifiedBy":"ONEDATA","dateModified":"2016-02-22","deletedIndicator":"No"},{"value":"Transient ischemic attack (TIA)","valueDescription":"Transient Ischemic Attack","ValueMeaning":{"publicId":"2944400","version":"1","preferredName":"Transient Ischemic Attack","longName":"2944400","preferredDefinition":"A brief attack (from a few minutes to an hour) of cerebral dysfunction of vascular origin, with no persistent neurological deficit.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Transient Ischemic Attack","conceptCode":"C50781","definition":"A brief attack (from a few minutes to an hour) of cerebral dysfunction of vascular origin, with no persistent neurological deficit.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7431FEA7-FCE7-A5C9-E040-BB89AD4324B4","latestVersionIndicator":"Yes","beginDate":"2009-09-22","endDate":null,"createdBy":"CURTIST","dateCreated":"2009-09-22","modifiedBy":"ONEDATA","dateModified":"2023-09-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2C612778-DB3F-0559-E050-BB89AD430531","beginDate":"2015-03-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-22","modifiedBy":"ONEDATA","dateModified":"2016-02-22","deletedIndicator":"No"},{"value":"Stroke","valueDescription":"Cerebrovascular Accident","ValueMeaning":{"publicId":"4733294","version":"1","preferredName":"Cerebrovascular Accident","longName":"4733294","preferredDefinition":"A sudden loss of neurological function secondary to hemorrhage or ischemia in the brain parenchyma due to a vascular event.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stroke","conceptCode":"C3390","definition":"A sudden loss of neurological function secondary to hemorrhage or ischemia in the brain parenchyma due to a vascular event.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"107BC70C-A141-B0D0-E050-BB89AD432FE8","latestVersionIndicator":"Yes","beginDate":"2015-03-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-03-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2C612778-DB49-0559-E050-BB89AD430531","beginDate":"2015-03-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-22","modifiedBy":"ONEDATA","dateModified":"2016-02-22","deletedIndicator":"No"},{"value":"Neuropathy","valueDescription":"NEUROPATHY","ValueMeaning":{"publicId":"2570463","version":"1","preferredName":"NEUROPATHY","longName":"2570463","preferredDefinition":"A disorder affecting the cranial nerves or the peripheral nervous system.  It is manifested with pain, tingling, numbness, and muscle weakness.  It may be the result of physical injury, toxic substances, viral diseases, diabetes, renal failure, cancer, and drugs. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neuropathy","conceptCode":"C4731","definition":"A disorder affecting the cranial nerves or the peripheral nervous system. It manifests with pain, tingling, numbness, and muscle weakness. It may be the result of physical injury, toxic substances, viral diseases, diabetes, renal failure, cancer, and drugs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E04C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2C612778-DB5D-0559-E050-BB89AD430531","beginDate":"2015-03-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-22","modifiedBy":"ONEDATA","dateModified":"2016-02-22","deletedIndicator":"No"},{"value":"CNS hemorrhage","valueDescription":"Central Nervous System Hemorrhage","ValueMeaning":{"publicId":"4733295","version":"1","preferredName":"Central Nervous System Hemorrhage","longName":"4733295","preferredDefinition":"The part of the nervous system that consists of the brain, spinal cord, and meninges.: Bleeding or escape of blood from a vessel.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Central Nervous System","conceptCode":"C12438","definition":"The part of the nervous system that consists of the brain, spinal cord, and meninges.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Hemorrhage","conceptCode":"C26791","definition":"The flow of blood from a ruptured blood vessel.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"107BC70C-A184-B0D0-E050-BB89AD432FE8","latestVersionIndicator":"Yes","beginDate":"2015-03-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-03-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2C612778-DB67-0559-E050-BB89AD430531","beginDate":"2015-03-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-22","modifiedBy":"ONEDATA","dateModified":"2016-02-22","deletedIndicator":"No"},{"value":"Pericarditis","valueDescription":"Pericarditis","ValueMeaning":{"publicId":"2566218","version":"1","preferredName":"Pericarditis","longName":"2566218","preferredDefinition":"An inflammatory process affecting the pericardium.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pericarditis","conceptCode":"C34915","definition":"An inflammatory process affecting the pericardium.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CFB7-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-07-24","endDate":null,"createdBy":"CHANGM","dateCreated":"2003-07-24","modifiedBy":"CURTIST","dateModified":"2011-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2C612778-DB71-0559-E050-BB89AD430531","beginDate":"2015-03-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-22","modifiedBy":"ONEDATA","dateModified":"2016-02-22","deletedIndicator":"No"},{"value":"VOD","valueDescription":"Veno-Occlusive Disease","ValueMeaning":{"publicId":"2768635","version":"1","preferredName":"Veno-Occlusive Disease","longName":"2768635","preferredDefinition":"Disorder in which veins are partially or completely obstructed or the blood flow through the veins is suboptimal.--2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Veno-Occlusive Disease","conceptCode":"C8301","definition":"Disorder in which veins are partially or completely obstructed or the blood flow through the veins is suboptimal.--2004","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"52DDF902-A307-5647-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"CZECHS","dateCreated":"2008-07-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2C612778-DB7B-0559-E050-BB89AD430531","beginDate":"2015-03-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-22","modifiedBy":"ONEDATA","dateModified":"2016-02-22","deletedIndicator":"No"},{"value":"Cirrhosis","valueDescription":"Cirrhosis","ValueMeaning":{"publicId":"2558505","version":"1","preferredName":"Cirrhosis","longName":"2558505","preferredDefinition":"A disorder characterized by replacement of the liver parenchyma with fibrous tissue and regenerative nodules. It is usually caused by alcoholisms, hepatitis B, and hepatitis C. Complications include the development of ascites, esophageal varices, bleeding, and hepatic encephalopathy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cirrhosis","conceptCode":"C2951","definition":"A disorder characterized by replacement of the liver parenchyma with fibrous tissue and regenerative nodules. It is usually caused by alcoholism, hepatitis B, and hepatitis C. Complications include the development of ascites, esophageal varices, bleeding, and hepatic encephalopathy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B196-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"CURTIST","dateModified":"2011-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2C612778-DB85-0559-E050-BB89AD430531","beginDate":"2015-03-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-22","modifiedBy":"ONEDATA","dateModified":"2016-02-22","deletedIndicator":"No"},{"value":"Gastrointestinal (GI) bleed","valueDescription":"Gastrointestinal Hemorrhage","ValueMeaning":{"publicId":"4293949","version":"1","preferredName":"Gastrointestinal Hemorrhage","longName":"4293949","preferredDefinition":"Bleeding originating from any part of the gastrointestinal tract.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastrointestinal Hemorrhage","conceptCode":"C48592","definition":"Bleeding originating from any part of the gastrointestinal tract.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8D473D5-41E7-380F-E040-BB89AD43084E","latestVersionIndicator":"Yes","beginDate":"2014-05-07","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2C612778-DB8F-0559-E050-BB89AD430531","beginDate":"2015-03-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-22","modifiedBy":"ONEDATA","dateModified":"2016-02-22","deletedIndicator":"No"},{"value":"Diarrhea requiring therapy","valueDescription":"Diarrhea Requirement Therapeutic Procedure","ValueMeaning":{"publicId":"4733311","version":"1","preferredName":"Diarrhea Requirement Therapeutic Procedure","longName":"4733311","preferredDefinition":"Watery bowel movements.: Something that is a necessary condition; something that is obligatory.: An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diarrhea","conceptCode":"C2987","definition":"Watery bowel movements.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Requirement","conceptCode":"C25652","definition":"Something that is a necessary condition; something that is obligatory.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"107BC70C-A1F5-B0D0-E050-BB89AD432FE8","latestVersionIndicator":"Yes","beginDate":"2015-03-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-03-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2C612778-DB99-0559-E050-BB89AD430531","beginDate":"2015-03-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-22","modifiedBy":"ONEDATA","dateModified":"2016-02-22","deletedIndicator":"No"},{"value":"Thrombotic microangiopathy (TMA)","valueDescription":"Thrombotic Microangiopathy","ValueMeaning":{"publicId":"4733314","version":"1","preferredName":"Thrombotic Microangiopathy","longName":"4733314","preferredDefinition":"The syndromes of microangiopathic hemolytic anemia, thrombocytopenia, and variable signs of organ impairment, due to platelet aggregation in the microcirculation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thrombotic Microangiopathy","conceptCode":"C62605","definition":"A microvascular coagulopathy that may result from systemic vascular endothelial injury triggering the development of a procoagulant state, activation of the complement cascade, and microthrombi formation. Signs may include hemolytic anemia, thrombocytopenia, hypertension and renal dysfunction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"107BC70C-A242-B0D0-E050-BB89AD432FE8","latestVersionIndicator":"Yes","beginDate":"2015-03-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-03-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2C612778-DBAD-0559-E050-BB89AD430531","beginDate":"2015-03-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-22","modifiedBy":"ONEDATA","dateModified":"2016-02-22","deletedIndicator":"No"},{"value":"Pulmonary or diffuse alveolar hemorrhage","valueDescription":"Pulmonary Hemorrhage Or Pulmonary Alveolar Hemorrhage","ValueMeaning":{"publicId":"4733325","version":"1","preferredName":"Pulmonary Hemorrhage Or Pulmonary Alveolar Hemorrhage","longName":"4733325","preferredDefinition":"Bleeding from the lung parenchyma.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: Bleeding in the alveoli.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pulmonary Hemorrhage","conceptCode":"C78578","definition":"Bleeding from the lung parenchyma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Pulmonary Alveolar Hemorrhage","conceptCode":"C116334","definition":"Bleeding in the alveoli.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"107BC70C-A291-B0D0-E050-BB89AD432FE8","latestVersionIndicator":"Yes","beginDate":"2015-03-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-03-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2C612778-DBB7-0559-E050-BB89AD430531","beginDate":"2015-03-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-22","modifiedBy":"ONEDATA","dateModified":"2016-02-22","deletedIndicator":"No"},{"value":"Fibrosis","valueDescription":"Fibrosis","ValueMeaning":{"publicId":"4264818","version":"1","preferredName":"Fibrosis","longName":"4264818","preferredDefinition":"The formation of fibrous tissue.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fibrosis","conceptCode":"C3044","definition":"The formation of fibrous tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F67A42EF-FCDE-5F77-E040-BB89AD433177","latestVersionIndicator":"Yes","beginDate":"2014-04-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-07","modifiedBy":"COOPERM","dateModified":"2020-10-16","changeDescription":"10.16.2020 Updated definition to match current NCIt. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2C612778-DBC1-0559-E050-BB89AD430531","beginDate":"2015-03-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-22","modifiedBy":"ONEDATA","dateModified":"2016-02-22","deletedIndicator":"No"},{"value":"Post-traumatic stress disorder (PTSD) requiring therapy","valueDescription":"Post-Traumatic Stress Disorder Requirement Therapeutic Procedure","ValueMeaning":{"publicId":"4733326","version":"1","preferredName":"Post-Traumatic Stress Disorder Requirement Therapeutic Procedure","longName":"4733326","preferredDefinition":"A class of traumatic stress disorders with symptoms that last more than one month. There are various forms of post-traumatic stress disorder, depending on the time of onset and the duration of these stress symptoms. In the acute form, the duration of the symptoms is between 1 to 3 months. In the chronic form, symptoms last more than 3 months. With delayed onset, symptoms develop more than 6 months after the traumatic event.: Something that is a necessary condition; something that is obligatory.: An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Post-Traumatic Stress Disorder","conceptCode":"C3389","definition":"An anxiety disorder precipitated by an experience of intense fear or horror while exposed to a traumatic (especially life-threatening) event. The disorder is characterized by intrusive recurring thoughts or images of the traumatic event; avoidance of anything associated with the event; a state of hyperarousal and diminished emotional responsiveness. These symptoms are present for at least one month and the disorder is usually long-term.","evsSource":"RADLEX_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Requirement","conceptCode":"C25652","definition":"Something that is a necessary condition; something that is obligatory.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"107BC70C-A2C2-B0D0-E050-BB89AD432FE8","latestVersionIndicator":"Yes","beginDate":"2015-03-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-03-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2C612778-DBCB-0559-E050-BB89AD430531","beginDate":"2015-03-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-22","modifiedBy":"ONEDATA","dateModified":"2016-02-22","deletedIndicator":"No"},{"value":"Anxiety requiring therapy","valueDescription":"Anxiety Requirement Therapeutic Procedure","ValueMeaning":{"publicId":"4733327","version":"1","preferredName":"Anxiety Requirement Therapeutic Procedure","longName":"4733327","preferredDefinition":"Apprehension of danger and dread accompanied by restlessness, tension, tachycardia, and dyspnea unattached to a clearly identifiable stimulus.: Something that is a necessary condition; something that is obligatory.: An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anxiety","conceptCode":"C26696","definition":"Apprehension of danger and dread accompanied by restlessness, tension, tachycardia, and dyspnea unattached to a clearly identifiable stimulus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Requirement","conceptCode":"C25652","definition":"Something that is a necessary condition; something that is obligatory.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"107BC70C-A2E9-B0D0-E050-BB89AD432FE8","latestVersionIndicator":"Yes","beginDate":"2015-03-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-03-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2C612778-DBD5-0559-E050-BB89AD430531","beginDate":"2015-03-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-22","modifiedBy":"ONEDATA","dateModified":"2016-02-22","deletedIndicator":"No"},{"value":"Depression requiring therapy","valueDescription":"Depression Requirement Therapeutic Procedure","ValueMeaning":{"publicId":"4733328","version":"1","preferredName":"Depression Requirement Therapeutic Procedure","longName":"4733328","preferredDefinition":"A melancholy feeling of sadness and despair.: Something that is a necessary condition; something that is obligatory.: An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Depression","conceptCode":"C2982","definition":"A melancholy feeling of sadness and despair.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Requirement","conceptCode":"C25652","definition":"Something that is a necessary condition; something that is obligatory.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"107BC70C-A310-B0D0-E050-BB89AD432FE8","latestVersionIndicator":"Yes","beginDate":"2015-03-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-03-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2C612778-DBDF-0559-E050-BB89AD430531","beginDate":"2015-03-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-22","modifiedBy":"ONEDATA","dateModified":"2016-02-22","deletedIndicator":"No"},{"value":"Osteoporosis","valueDescription":"Osteoporosis","ValueMeaning":{"publicId":"2563635","version":"1","preferredName":"Osteoporosis","longName":"2563635","preferredDefinition":"A condition of reduced bone mass, with decreased cortical thickness and a decrease in the number and size of the trabeculae of cancellous bone (but normal chemical composition), resulting in increased fracture incidence. Osteoporosis is classified as primary (Type 1, postmenopausal osteoporosis; Type 2, age-associated osteoporosis; and idiopathic, which can affect juveniles, premenopausal women, and middle-aged men) and secondary osteoporosis (which results from an identifiable cause of bone mass loss).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Osteoporosis","conceptCode":"C3298","definition":"A condition of reduced bone mass, with decreased cortical thickness and a decrease in the number and size of the trabeculae of cancellous bone (but normal chemical composition), resulting in increased fracture incidence. Osteoporosis is classified as primary (Type 1, postmenopausal osteoporosis; Type 2, age-associated osteoporosis; and idiopathic, which can affect juveniles, premenopausal women, and middle-aged men) and secondary osteoporosis (which results from an identifiable cause of bone mass loss).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C5A0-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-12-05","endDate":null,"createdBy":"CVALMONT","dateCreated":"2002-12-05","modifiedBy":"CURTIST","dateModified":"2011-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2C612778-DBE9-0559-E050-BB89AD430531","beginDate":"2015-03-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-22","modifiedBy":"ONEDATA","dateModified":"2016-02-22","deletedIndicator":"No"},{"value":"Cryptogenic organizing pneumonia (COP / BOOP)","valueDescription":"Cryptogenic Organizing Pneumonia","ValueMeaning":{"publicId":"2804712","version":"1","preferredName":"Cryptogenic Organizing Pneumonia","longName":"2804712","preferredDefinition":"A disease formerly considered a form of interstitial pneumonia. Its etiology is obscure but it may be associated with toxic fumes, infection, and connective tissue disease. Clinical symptoms include cough, dyspnea and influenza-like symptoms with the development of the usual interstitial pneumonia in many cases. Obstructive symptoms are limited to smokers. There are patchy polypoid masses of intra-alveolar granulation tissue in small airway lumina and alveolar ducts. \"Organizing\" refers to unresolved pneumonia (in which the alveolar exudate persists and eventually undergoes fibrosis) in which fibrous tissue forms in the alveoli.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cryptogenic Organizing Pneumonia","conceptCode":"C62586","definition":"A form of organizing pneumonia with a non-infectious etiology. Excessive proliferation of granulation tissue occurs in alveolar ducts and alveoli and primarily causes injury to alveolar walls, but bronchioles may be affected.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5C7576B8-1938-1506-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"NYCHM","dateCreated":"2008-11-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2C612778-DBF3-0559-E050-BB89AD430531","beginDate":"2008-11-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-22","modifiedBy":"ONEDATA","dateModified":"2016-02-22","deletedIndicator":"No"},{"value":"Interstitial pneumonitis (IPn) / ARDS","valueDescription":"Idiopathic Pneumonia Syndrome Or Adult Respiratory Distress Syndrome","ValueMeaning":{"publicId":"2804711","version":"1","preferredName":"Idiopathic Pneumonia Syndrome Or Adult Respiratory Distress Syndrome","longName":"2804711","preferredDefinition":"An inflammatory lung disease characterized by diffuse interstitial pneumonitis and alveolitis leading to interstitial fibrosis in the absence of an identifiable infectious agent.: Or; used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: fulminant pulmonary interstitial and alveolar edema resulting from diffuse infection, shock, or trauma of the lungs.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Idiopathic Pneumonia Syndrome","conceptCode":"C62590","definition":"An inflammatory lung disease characterized by diffuse interstitial pneumonitis and alveolitis leading to interstitial fibrosis in the absence of an identifiable infectious agent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Acute Respiratory Distress Syndrome","conceptCode":"C3353","definition":"Progressive and life-threatening pulmonary distress in the absence of an underlying pulmonary condition, usually following major trauma or surgery. Cases of neonatal respiratory distress syndrome are not included in this definition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5C7576B8-18FE-1506-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"NYCHM","dateCreated":"2008-11-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2C612778-DBFD-0559-E050-BB89AD430531","beginDate":"2008-11-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-22","modifiedBy":"ONEDATA","dateModified":"2016-02-22","deletedIndicator":"No"},{"value":"Encephalopathy","valueDescription":"Encephalopathy","ValueMeaning":{"publicId":"4395764","version":"1","preferredName":"Encephalopathy","longName":"4395764","preferredDefinition":"A functional and/or structural disorder of the brain caused by diseases (e.g. liver disease, kidney disease), medications, chemicals, and injuries.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Encephalopathy","conceptCode":"C26920","definition":"A functional and/or structural disorder of the brain caused by diseases (e.g. liver disease, kidney disease), medications, chemicals, and injuries.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEB8F754-D875-8D06-E040-BB89AD437F49","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2C612778-DC07-0559-E050-BB89AD430531","beginDate":"2015-03-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-22","modifiedBy":"ONEDATA","dateModified":"2016-02-22","deletedIndicator":"No"},{"value":"Arrhythmia","valueDescription":"Arrhythmia","ValueMeaning":{"publicId":"4733351","version":"1","preferredName":"Arrhythmia","longName":"4733351","preferredDefinition":"Any variation from the normal rate or rhythm (which may include the origin of the impulse and/or its subsequent propagation) in the heart.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Arrhythmia","conceptCode":"C2881","definition":"Any variation from the normal rate or rhythm (which may include the origin of the impulse and/or its subsequent propagation) in the heart.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"107BC70C-A38B-B0D0-E050-BB89AD432FE8","latestVersionIndicator":"Yes","beginDate":"2015-03-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-03-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2C612778-DC11-0559-E050-BB89AD430531","beginDate":"2015-03-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-22","modifiedBy":"ONEDATA","dateModified":"2016-02-22","deletedIndicator":"No"},{"value":"Strictures","valueDescription":"Stenosis","ValueMeaning":{"publicId":"4395741","version":"1","preferredName":"Stenosis","longName":"4395741","preferredDefinition":"Narrowing or stricture of a vessel, duct or canal.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stenosis","conceptCode":"C50754","definition":"Narrowing or stricture of a vessel, duct or canal.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEB8F754-D526-8D06-E040-BB89AD437F49","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2C612778-DC1B-0559-E050-BB89AD430531","beginDate":"2015-03-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-22","modifiedBy":"ONEDATA","dateModified":"2016-02-22","deletedIndicator":"No"},{"value":"Coronary artery disease","valueDescription":"Coronary Disease","ValueMeaning":{"publicId":"2760269","version":"1","preferredName":"Coronary Disease","longName":"2760269","preferredDefinition":"An imbalance between myocardial functional requirements and the capacity of the coronary vessels to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Coronary Artery Disease","conceptCode":"C26732","definition":"Narrowing of the coronary arteries due to fatty deposits inside the arterial walls. The diagnostic criteria may include documented history of any of the following: documented coronary artery stenosis greater than or equal to 50% (by cardiac catheterization or other modality of direct imaging of the coronary arteries); previous coronary artery bypass surgery (CABG); previous percutaneous coronary intervention (PCI); previous myocardial infarction. (ACC)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4FF5CBC6-3CA7-1060-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"CZECHS","dateCreated":"2008-06-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2C612778-DC4F-0559-E050-BB89AD430531","beginDate":"2016-02-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-22","modifiedBy":"ONEDATA","dateModified":"2016-02-22","deletedIndicator":"No"},{"value":"Congestive heart failure","valueDescription":"Congestive heart failure","ValueMeaning":{"publicId":"2565944","version":"1","preferredName":"Congestive heart failure","longName":"2565944","preferredDefinition":"Failure of the heart to pump a sufficient amount of blood to meet the needs of the body tissues, resulting in tissue congestion and edema. Signs and symptoms include shortness of breath, pitting edema, enlarged tender liver, engorged neck veins, and pulmonary rales.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Congestive Heart Failure","conceptCode":"C3080","definition":"Failure of the heart to pump a sufficient amount of blood to meet the needs of the body tissues, resulting in tissue congestion and edema. Signs and symptoms include shortness of breath, pitting edema, enlarged tender liver, engorged neck veins, and pulmonary rales.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CEA5-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-05-19","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-05-19","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2C612778-DC59-0559-E050-BB89AD430531","beginDate":"2016-02-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-22","modifiedBy":"ONEDATA","dateModified":"2016-02-22","deletedIndicator":"No"},{"value":"Hypertension (HTN) requiring therapy","valueDescription":"Hypertension Requirement Therapeutic Procedure","ValueMeaning":{"publicId":"4733293","version":"1","preferredName":"Hypertension Requirement Therapeutic Procedure","longName":"4733293","preferredDefinition":"Blood pressure that is abnormally high.: Something that is a necessary condition; something that is obligatory.: An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hypertension","conceptCode":"C3117","definition":"Blood pressure that is abnormally high.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Requirement","conceptCode":"C25652","definition":"Something that is a necessary condition; something that is obligatory.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"107BC70C-A10A-B0D0-E050-BB89AD432FE8","latestVersionIndicator":"Yes","beginDate":"2015-03-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-03-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2C612778-DC6D-0559-E050-BB89AD430531","beginDate":"2015-03-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-22","modifiedBy":"ONEDATA","dateModified":"2016-02-22","deletedIndicator":"No"},{"value":"Seizures","valueDescription":"Seizure","ValueMeaning":{"publicId":"2946180","version":"1","preferredName":"Seizure","longName":"2946180","preferredDefinition":"Sudden, involuntary skeletal muscular contractions of cerebral or brain stem origin.--2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Seizure","conceptCode":"C2962","definition":"Sudden, involuntary skeletal muscular contractions of cerebral or brain stem origin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746BFDBA-4A04-B144-E040-BB89AD4341DF","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2C612778-DC77-0559-E050-BB89AD430531","beginDate":"2015-03-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-22","modifiedBy":"ONEDATA","dateModified":"2016-02-22","deletedIndicator":"No"},{"value":"Non-infectious interstitial pneumonitis (IPn or ARDS) / idiopathic pneumonia syndrome (IPS)","valueDescription":"Negation Infectious Disorder Interstitial Pneumonia And/Or Idiopathic Pneumonia Syndrome","ValueMeaning":{"publicId":"6272167","version":"1","preferredName":"Negation Infectious Disorder Interstitial Pneumonia And/Or Idiopathic Pneumonia Syndrome","longName":"6272167","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction.: A disorder resulting from the presence and activity of a microbial, viral, fungal, or parasitic agent. It can be transmitted by direct or indirect contact.: Inflammation of interstitial lung tissue, usually associated with infection.: Used to indicate that either or both of two items or options may be valid.: An inflammatory lung disease characterized by diffuse interstitial pneumonitis and alveolitis leading to interstitial fibrosis in the absence of an identifiable infectious agent.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Infectious Disorder","conceptCode":"C26726","definition":"A disorder resulting from the presence and activity of a microbial, viral, fungal, or parasitic agent. It can be transmitted by direct or indirect contact.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Interstitial Pneumonia","conceptCode":"C27006","definition":"Inflammation of interstitial lung tissue, usually associated with infection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"And/Or","conceptCode":"C48928","definition":"Used to indicate that either or both of two items or options may be valid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Idiopathic Pneumonia Syndrome","conceptCode":"C62590","definition":"An inflammatory lung disease characterized by diffuse interstitial pneumonitis and alveolitis leading to interstitial fibrosis in the absence of an identifiable infectious agent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6BC5AD54-B8D4-539A-E053-F662850A62C3","latestVersionIndicator":"Yes","beginDate":"2018-05-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-05-09","modifiedBy":"ONEDATA","dateModified":"2018-05-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6BCDE6C1-4778-461D-E053-F662850A57EB","beginDate":"2018-05-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-05-10","modifiedBy":"ONEDATA","dateModified":"2018-05-10","deletedIndicator":"No"},{"value":"Acute renal failure requiring dialysis","valueDescription":"Acute Renal Failure Requirement Dialysis","ValueMeaning":{"publicId":"6272179","version":"1","preferredName":"Acute Renal Failure Requirement Dialysis","longName":"6272179","preferredDefinition":"Sudden and sustained deterioration of the kidney function characterized by decreased glomerular filtration rate, increased serum creatinine or oliguria.: Something that is a necessary condition; something that is obligatory.: A procedure to remove toxic substances from the blood that is used in patients with end-stage chronic kidney disease or acute kidney failure. This includes hemodialysis and peritoneal dialysis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acute Renal Failure","conceptCode":"C26808","definition":"Sudden and sustained deterioration of the kidney function characterized by decreased glomerular filtration rate, increased serum creatinine or oliguria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Requirement","conceptCode":"C25652","definition":"Something that is a necessary condition; something that is obligatory.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Dialysis","conceptCode":"C15221","definition":"A procedure to remove toxic substances from the blood that is used in patients with end-stage chronic kidney disease or acute kidney failure. This includes hemodialysis and peritoneal dialysis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6BC72690-606F-1A59-E053-F662850A0CB1","latestVersionIndicator":"Yes","beginDate":"2018-05-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-05-09","modifiedBy":"ONEDATA","dateModified":"2018-05-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6BC72690-6088-1A59-E053-F662850A0CB1","beginDate":"2018-05-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-05-09","modifiedBy":"ONEDATA","dateModified":"2018-05-09","deletedIndicator":"No"},{"value":"Infection","valueDescription":"Infectious Disorder","ValueMeaning":{"publicId":"4824551","version":"1","preferredName":"Infectious Disorder","longName":"4824551","preferredDefinition":"A disorder resulting from the presence and activity of a microbial, viral, fungal, or parasitic agent. It can be transmitted by direct or indirect contact.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Infectious Disorder","conceptCode":"C26726","definition":"A disorder resulting from the presence and activity of a microbial, viral, fungal, or parasitic agent. It can be transmitted by direct or indirect contact.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15F5F0DF-BD14-EF20-E050-BB89AD431CD6","latestVersionIndicator":"Yes","beginDate":"2015-05-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-05-13","modifiedBy":"KUMMEROA","dateModified":"2023-04-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6BC5AD54-B901-539A-E053-F662850A62C3","beginDate":"2018-05-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-05-09","modifiedBy":"ONEDATA","dateModified":"2018-05-09","deletedIndicator":"No"},{"value":"New malignancy","valueDescription":"New Malignant Neoplasm","ValueMeaning":{"publicId":"4732513","version":"1","preferredName":"New Malignant Neoplasm","longName":"4732513","preferredDefinition":"Having no previous example or precedent or parallel; of a kind not seen before.: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"New","conceptCode":"C25586","definition":"Having no previous example or precedent or parallel; of a kind not seen before.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"10694E6B-6DAC-79A6-E050-BB89AD433E9A","latestVersionIndicator":"Yes","beginDate":"2015-03-03","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-03-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6BC5AD54-B8F7-539A-E053-F662850A62C3","beginDate":"2018-05-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-05-09","modifiedBy":"ONEDATA","dateModified":"2018-05-09","deletedIndicator":"No"},{"value":"GVHD","valueDescription":"Graft Versus Host Disease","ValueMeaning":{"publicId":"2636869","version":"1","preferredName":"Graft Versus Host Disease","longName":"2636869","preferredDefinition":"An incompatibility reaction (which may be fatal) in a subject (host) of low immunological competence (deficient lymphoid tissue) who has been the recipient of immunologically competent lymphoid tissue from a donor who lacks at least one antigen possessed by the recipient host; the reaction, or disease, is the result of action of the transplanted cells against those host tissues that possess the antigen not possessed by the donor. Seen most commonly following bone marrow transplantation, acute disease is seen after 5-40 days and chronic disease weeks to months after transplantation, affecting, principally, the gastrointestinal tract, liver, and skin.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Graft Versus Host Disease","conceptCode":"C3063","definition":"A reaction, which may be fatal, in an immunocompromised subject (host) who has received an antigenically incompatible tissue transplant (graft) from an immunocompetent donor. The reaction is secondary to the activation of the transplanted cells against those host tissues that express an antigen not expressed by the donor, and is seen most commonly following bone marrow transplantation; acute disease is seen after 5-40 days, and chronic disease occurs weeks to months after transplantation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FF979BE-A605-6817-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-08","endDate":null,"createdBy":"MAESKEB","dateCreated":"2007-05-08","modifiedBy":"GDEEN","dateModified":"2023-06-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6BC5AD54-B90B-539A-E053-F662850A62C3","beginDate":"2018-05-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-05-09","modifiedBy":"ONEDATA","dateModified":"2018-05-09","deletedIndicator":"No"},{"value":"Diffuse alveolar hemorrhage","valueDescription":"Diffuse Pulmonary Alveolar Hemorrhage","ValueMeaning":{"publicId":"5021904","version":"1","preferredName":"Diffuse Pulmonary Alveolar Hemorrhage","longName":"5021904","preferredDefinition":"widely spread; not localized or confined.: Bleeding in the alveoli.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diffuse","conceptCode":"C14175","definition":"Widely spread; not localized or confined.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Pulmonary Alveolar Hemorrhage","conceptCode":"C116334","definition":"Bleeding in the alveoli.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2047C974-49B6-BBB9-E050-BB89AD4355F1","latestVersionIndicator":"Yes","beginDate":"2015-09-21","endDate":null,"createdBy":"SORENSENS","dateCreated":"2015-09-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6BC5AD54-B915-539A-E053-F662850A62C3","beginDate":"2018-05-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-05-09","modifiedBy":"ONEDATA","dateModified":"2018-05-09","deletedIndicator":"No"},{"value":"Other non-infectious pulmonary abnormality","valueDescription":"Other Negation Infectious Disorder Pulmonary Abnormality","ValueMeaning":{"publicId":"7615685","version":"1","preferredName":"Other Negation Infectious Disorder Pulmonary Abnormality","longName":"7615685","preferredDefinition":"Different than the one(s) previously specified or mentioned.: An operation in which a term denies or inverts the meaning of another term or construction.: A disorder resulting from the presence and activity of a microbial, viral, fungal, or parasitic agent. It can be transmitted by direct or indirect contact.: Having to do with the lungs.: A condition that differs from the usual physical or mental state.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Infectious Disorder","conceptCode":"C26726","definition":"A disorder resulting from the presence and activity of a microbial, viral, fungal, or parasitic agent. It can be transmitted by direct or indirect contact.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Pulmonary","conceptCode":"C13304","definition":"Relating to the lungs as the intended site of administration, where the pharmaceutical product is administered, usually by inhalation, for local action in the lower respiratory tract or for systemic action after absorption via the lower respiratory tract.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Abnormality","conceptCode":"C9440","definition":"A condition that differs from the usual physical or mental state.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BE7533FD-6466-1DD1-E053-4EBD850ACCFA","latestVersionIndicator":"Yes","beginDate":"2021-03-26","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-03-26","modifiedBy":"ONEDATA","dateModified":"2021-03-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE7533FD-647F-1DD1-E053-4EBD850ACCFA","beginDate":"2021-03-26","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-03-26","modifiedBy":"ONEDATA","dateModified":"2021-03-26","deletedIndicator":"No"},{"value":"None","valueDescription":"None","ValueMeaning":{"publicId":"4001711","version":"1","preferredName":"None","longName":"4001711","preferredDefinition":"No person or thing, nobody, not any.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"None","conceptCode":"C41132","definition":"No person or thing, nobody, not any.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ED6DCE6B-B411-EF30-E040-BB89AD4369A8","latestVersionIndicator":"Yes","beginDate":"2013-12-13","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2013-12-13","modifiedBy":"GDEEN","dateModified":"2024-01-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE7533FD-6489-1DD1-E053-4EBD850ACCFA","beginDate":"2021-03-26","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-03-26","modifiedBy":"ONEDATA","dateModified":"2021-03-26","deletedIndicator":"No"},{"value":"Stroke / transient ischemic attack","valueDescription":"Cerebrovascular Accident Or Transient Ischemic Attack","ValueMeaning":{"publicId":"7618252","version":"1","preferredName":"Cerebrovascular Accident Or Transient Ischemic Attack","longName":"7618252","preferredDefinition":"A sudden loss of neurological function secondary to hemorrhage or ischemia in the brain parenchyma due to a vascular event.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: A brief attack (from a few minutes to an hour) of cerebral dysfunction of vascular origin, with no persistent neurological deficit.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stroke","conceptCode":"C3390","definition":"A sudden loss of neurological function secondary to hemorrhage or ischemia in the brain parenchyma due to a vascular event.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Transient Ischemic Attack","conceptCode":"C50781","definition":"A brief attack (from a few minutes to an hour) of cerebral dysfunction of vascular origin, with no persistent neurological deficit.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BE77D843-6C90-7BD7-E053-4EBD850AA729","latestVersionIndicator":"Yes","beginDate":"2021-03-26","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-03-26","modifiedBy":"ONEDATA","dateModified":"2021-03-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE77D843-6CA9-7BD7-E053-4EBD850AA729","beginDate":"2021-03-26","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-03-26","modifiedBy":"ONEDATA","dateModified":"2021-03-26","deletedIndicator":"No"},{"value":"Pulmonary embolism","valueDescription":"Pulmonary Embolism","ValueMeaning":{"publicId":"4395768","version":"1","preferredName":"Pulmonary Embolism","longName":"4395768","preferredDefinition":"The obstruction of the pulmonary artery or one of its branches by an embolus, sometimes associated with infarction of the lung.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pulmonary Embolism","conceptCode":"C50713","definition":"The obstruction of the pulmonary artery or one of its branches by an embolus, sometimes associated with infarction of the lung.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEB8F754-D8E1-8D06-E040-BB89AD437F49","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-21","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE739ABF-6F59-4232-E053-4EBD850AA1CD","beginDate":"2021-03-26","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-03-26","modifiedBy":"ONEDATA","dateModified":"2021-03-26","deletedIndicator":"No"},{"value":"Deep vein thrombosis (DVT)","valueDescription":"Deep Vein Thrombosis","ValueMeaning":{"publicId":"5296770","version":"1","preferredName":"Deep Vein Thrombosis","longName":"5296770","preferredDefinition":"A blood clot in a deep vein, predominantly in the lower extremity, but may include the pelvis or upper extremity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Deep Vein Thrombosis","conceptCode":"C49343","definition":"A blood clot in a deep vein, predominantly in the lower extremity, but may include the pelvis or upper extremity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3565D051-59F6-E09A-E050-BB89AD4359CB","latestVersionIndicator":"Yes","beginDate":"2016-06-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-16","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE739ABF-6F6D-4232-E053-4EBD850AA1CD","beginDate":"2021-03-26","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-03-26","modifiedBy":"ONEDATA","dateModified":"2021-03-26","deletedIndicator":"No"},{"value":"Heart valve disease","valueDescription":"Valvular Heart Disorder","ValueMeaning":{"publicId":"3210765","version":"1","preferredName":"Valvular Heart Disorder","longName":"3210765","preferredDefinition":"Any heart disorder characterized by a defect in valve structure or function.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Valvular Heart Disorder","conceptCode":"C45525","definition":"Any heart disorder characterized by a defect in valve structure or function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-9C32-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE739ABF-6F81-4232-E053-4EBD850AA1CD","beginDate":"2021-03-26","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-03-26","modifiedBy":"ONEDATA","dateModified":"2021-03-26","deletedIndicator":"No"},{"value":"Hyperlipidemia","valueDescription":"Hyperlipidemia","ValueMeaning":{"publicId":"2751390","version":"1","preferredName":"Hyperlipidemia","longName":"2751390","preferredDefinition":"An excess of lipids in the blood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hyperlipidemia","conceptCode":"C34707","definition":"Elevated levels of lipids in the blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DC907AE-0915-716C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE739ABF-6F8B-4232-E053-4EBD850AA1CD","beginDate":"2021-03-26","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-03-26","modifiedBy":"ONEDATA","dateModified":"2021-03-26","deletedIndicator":"No"},{"value":"Myocardial infarction","valueDescription":"Myocardial Infarction","ValueMeaning":{"publicId":"2570461","version":"1","preferredName":"Myocardial Infarction","longName":"2570461","preferredDefinition":"Gross necrosis of the myocardium, as a result of interruption of the blood supply to the area, as in coronary thrombosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myocardial Infarction","conceptCode":"C27996","definition":"Gross necrosis of the myocardium, as a result of interruption of the blood supply to the area, as in coronary thrombosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E04A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"MAESKEB","dateModified":"2022-04-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE739ABF-6F95-4232-E053-4EBD850AA1CD","beginDate":"2021-03-26","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-03-26","modifiedBy":"ONEDATA","dateModified":"2021-03-26","deletedIndicator":"No"},{"value":"Unstable angina","valueDescription":"Unstable Angina","ValueMeaning":{"publicId":"5296761","version":"1","preferredName":"Unstable Angina","longName":"5296761","preferredDefinition":"Angina pectoris (or equivalent type of ischemic discomfort) which has recently changed in frequency, duration, intensity, or occurs at rest.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unstable Angina","conceptCode":"C66911","definition":"Angina pectoris (or equivalent type of ischemic discomfort) which has recently changed in frequency, duration, intensity, or occurs at rest.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3565CB75-DAD7-7159-E050-BB89AD43431B","latestVersionIndicator":"Yes","beginDate":"2016-06-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE739ABF-6F9F-4232-E053-4EBD850AA1CD","beginDate":"2021-03-26","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-03-26","modifiedBy":"ONEDATA","dateModified":"2021-03-26","deletedIndicator":"No"},{"value":"Cardiomyopathy","valueDescription":"Cardiomyopathy","ValueMeaning":{"publicId":"2585212","version":"1","preferredName":"Cardiomyopathy","longName":"2585212","preferredDefinition":"A disease of the heart muscle or myocardium proper. Cardiomyopathies may be classified as either primary or secondary, on the basis of etiology, or on the pathophysiology of the lesion: hypertrophic, dilated, or restrictive.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cardiomyopathy","conceptCode":"C34830","definition":"A disease of the heart muscle or myocardium proper. Cardiomyopathies may be classified as either primary or secondary, on the basis of etiology, or on the pathophysiology of the lesion: hypertrophic, dilated, or restrictive.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2687D788-9B74-74B4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-01-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-01-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE739ABF-6FA9-4232-E053-4EBD850AA1CD","beginDate":"2021-03-26","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-03-26","modifiedBy":"ONEDATA","dateModified":"2021-03-26","deletedIndicator":"No"},{"value":"Chronic kidney disease / renal impairment","valueDescription":"Chronic Kidney Disease Or Renal Impairment","ValueMeaning":{"publicId":"7618250","version":"1","preferredName":"Chronic Kidney Disease Or Renal Impairment","longName":"7618250","preferredDefinition":"Impairment of the renal function secondary to chronic kidney damage persisting for three or more months.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: Diminished kidney function.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chronic Kidney Disease","conceptCode":"C80078","definition":"Impairment of the renal function secondary to chronic kidney damage persisting for three or more months.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Renal Impairment","conceptCode":"C114592","definition":"Diminished kidney function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BE739ABF-6FB7-4232-E053-4EBD850AA1CD","latestVersionIndicator":"Yes","beginDate":"2021-03-26","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-03-26","modifiedBy":"ONEDATA","dateModified":"2021-03-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE739ABF-6FD0-4232-E053-4EBD850AA1CD","beginDate":"2021-03-26","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-03-26","modifiedBy":"ONEDATA","dateModified":"2021-03-26","deletedIndicator":"No"},{"value":"Thrombosis","valueDescription":"Thrombosis","ValueMeaning":{"publicId":"4792371","version":"1","preferredName":"Thrombosis","longName":"4792371","preferredDefinition":"The formation of a blood clot in the lumen of a vessel or heart chamber; causes include coagulation disorders and vascular endothelial injury.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thrombosis","conceptCode":"C26891","definition":"The formation of a blood clot in the lumen of a vessel or heart chamber; causes include coagulation disorders and vascular endothelial injury.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"13DA6467-E753-681F-E050-BB89AD4305DE","latestVersionIndicator":"Yes","beginDate":"2015-04-16","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D785A1FD-115E-761E-E053-4EBD850A4BDD","beginDate":"2022-02-08","endDate":null,"createdBy":"MALUMK","dateCreated":"2022-02-08","modifiedBy":"ONEDATA","dateModified":"2022-02-08","deletedIndicator":"No"},{"value":"Retinal changes","valueDescription":"Retinal Change","ValueMeaning":{"publicId":"8030883","version":"1","preferredName":"Retinal Change","longName":"8030883","preferredDefinition":"Retinoid with an aldehyde group.: The act of alteration or modification; changed or altered in form or character.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Retinal","conceptCode":"C68300","definition":"Retinoid with an aldehyde group.","evsSource":"RADLEX_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Change","conceptCode":"C25446","definition":"The act of alteration or modification; changed or altered in form or character.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D785A1FD-116B-761E-E053-4EBD850A4BDD","latestVersionIndicator":"Yes","beginDate":"2022-02-08","endDate":null,"createdBy":"MALUMK","dateCreated":"2022-02-08","modifiedBy":"ONEDATA","dateModified":"2022-02-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D785A1FD-1184-761E-E053-4EBD850A4BDD","beginDate":"2022-02-08","endDate":null,"createdBy":"MALUMK","dateCreated":"2022-02-08","modifiedBy":"ONEDATA","dateModified":"2022-02-08","deletedIndicator":"No"},{"value":"Pulmonary hypertension","valueDescription":"Pulmonary Hypertension","ValueMeaning":{"publicId":"2946136","version":"1","preferredName":"Pulmonary Hypertension","longName":"2946136","preferredDefinition":"Increased pressure within the pulmonary circulation due to lung or heart disorder.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pulmonary Hypertension","conceptCode":"C3120","definition":"Increased pressure within the pulmonary circulation due to lung or heart disorder.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746AE5AE-6AEF-370C-E040-BB89AD4351E3","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D785A1FD-118E-761E-E053-4EBD850A4BDD","beginDate":"2022-02-08","endDate":null,"createdBy":"MALUMK","dateCreated":"2022-02-08","modifiedBy":"ONEDATA","dateModified":"2022-02-08","deletedIndicator":"No"},{"value":"Hypersplenism","valueDescription":"Hypersplenism","ValueMeaning":{"publicId":"8030885","version":"1","preferredName":"Hypersplenism","longName":"8030885","preferredDefinition":"Overactive functioning of the spleen, resulting in excessive destruction of blood cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hypersplenism","conceptCode":"C34714","definition":"Overactive functioning of the spleen, resulting in excessive destruction of blood cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D785A1FD-119B-761E-E053-4EBD850A4BDD","latestVersionIndicator":"Yes","beginDate":"2022-02-08","endDate":null,"createdBy":"MALUMK","dateCreated":"2022-02-08","modifiedBy":"ONEDATA","dateModified":"2022-02-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D785A1FD-11B4-761E-E053-4EBD850A4BDD","beginDate":"2022-02-08","endDate":null,"createdBy":"MALUMK","dateCreated":"2022-02-08","modifiedBy":"ONEDATA","dateModified":"2022-02-08","deletedIndicator":"No"},{"value":"Cholelithiasis","valueDescription":"Cholelithiasis","ValueMeaning":{"publicId":"6514326","version":"1","preferredName":"Cholelithiasis","longName":"6514326","preferredDefinition":"The presence of calculi in the gallbladder.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cholelithiasis","conceptCode":"C122822","definition":"The presence of calculi in the gallbladder.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7884A5FC-FB15-7ADF-E053-F662850A9A90","latestVersionIndicator":"Yes","beginDate":"2018-10-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-10-18","modifiedBy":"ONEDATA","dateModified":"2018-10-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D785A1FD-11BE-761E-E053-4EBD850A4BDD","beginDate":"2022-02-08","endDate":null,"createdBy":"MALUMK","dateCreated":"2022-02-08","modifiedBy":"ONEDATA","dateModified":"2022-02-08","deletedIndicator":"No"},{"value":"Amenorrhea","valueDescription":"Amenorrhea","ValueMeaning":{"publicId":"8030887","version":"1","preferredName":"Amenorrhea","longName":"8030887","preferredDefinition":"The absence of menses in a woman who has achieved reproductive age.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Amenorrhea","conceptCode":"C61443","definition":"The absence of menses in a woman who has achieved reproductive age.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D785A1FD-11CB-761E-E053-4EBD850A4BDD","latestVersionIndicator":"Yes","beginDate":"2022-02-08","endDate":null,"createdBy":"MALUMK","dateCreated":"2022-02-08","modifiedBy":"ONEDATA","dateModified":"2022-02-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D785A1FD-11E4-761E-E053-4EBD850A4BDD","beginDate":"2022-02-08","endDate":null,"createdBy":"MALUMK","dateCreated":"2022-02-08","modifiedBy":"ONEDATA","dateModified":"2022-02-08","deletedIndicator":"No"},{"value":"Osteopathies (porosis, penia)","valueDescription":"Thalassemic Osteopathy","ValueMeaning":{"publicId":"8048024","version":"1","preferredName":"Thalassemic Osteopathy","longName":"8048024","preferredDefinition":"Bone disorders that present in thalassemia patients.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thalassemic Osteopathy","conceptCode":"C185434","definition":"Bone disorders that present in thalassemia patients.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D83FD051-E4F2-194E-E053-4EBD850A161E","latestVersionIndicator":"Yes","beginDate":"2022-02-17","endDate":null,"createdBy":"MALUMK","dateCreated":"2022-02-17","modifiedBy":"ONEDATA","dateModified":"2022-02-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D83FD051-E50B-194E-E053-4EBD850A161E","beginDate":"2022-02-17","endDate":null,"createdBy":"MALUMK","dateCreated":"2022-02-17","modifiedBy":"ONEDATA","dateModified":"2022-02-17","deletedIndicator":"No"},{"value":"Growth hormone deficiency / growth disturbance","valueDescription":null,"ValueMeaning":{"publicId":"14712517","version":"1","preferredName":"Growth Hormone Deficiency And/Or Growth Failure","longName":"14712517v1.00","preferredDefinition":"Insufficient production of growth hormone._Used to indicate that either or both of two items or options may be valid._Less than normal linear growth in an infant or child.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Growth Hormone Deficiency","conceptCode":"C112835","definition":"Insufficient production of growth hormone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"And/Or","conceptCode":"C48928","definition":"Used to indicate that either or both of two items or options may be valid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Growth Failure","conceptCode":"C113100","definition":"Less than normal linear growth in an infant or child.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F4FBBF5-A06F-4E8E-E063-731AD00ABB55","latestVersionIndicator":"Yes","beginDate":"2024-01-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-19","modifiedBy":"KUMMEROA","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F4FBBF5-A071-4E8E-E063-731AD00ABB55","beginDate":"2024-01-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-19","modifiedBy":"KUMMEROA","dateModified":"2024-01-19","deletedIndicator":"No"},{"value":"Hemorrhagic cystitis / hematuria","valueDescription":null,"ValueMeaning":{"publicId":"14712518","version":"1","preferredName":"Hemorrhagic Cystitis And/Or Hematuria","longName":"14712518v1.00","preferredDefinition":"Inflammation of the bladder resulting in bloody urine._Used to indicate that either or both of two items or options may be valid._Blood in the urine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemorrhagic Cystitis","conceptCode":"C114666","definition":"Inflammation of the bladder resulting in bloody urine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"And/Or","conceptCode":"C48928","definition":"Used to indicate that either or both of two items or options may be valid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Hematuria","conceptCode":"C3090","definition":"Blood in the urine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F4FBBF5-A070-4E8E-E063-731AD00ABB55","latestVersionIndicator":"Yes","beginDate":"2024-01-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-19","modifiedBy":"KUMMEROA","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F4FBBF5-A072-4E8E-E063-731AD00ABB55","beginDate":"2024-01-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-19","modifiedBy":"KUMMEROA","dateModified":"2024-01-19","deletedIndicator":"No"},{"value":"Renal failure requiring dialysis","valueDescription":null,"ValueMeaning":{"publicId":"14712519","version":"1","preferredName":"Renal Failure Requirement Dialysis","longName":"14712519v1.00","preferredDefinition":"An acute or chronic condition that is characterized by the inability of the kidneys to adequately filter the blood._Something that is a necessary condition; something that is obligatory._A procedure to remove toxic substances from the blood that is used in patients with end-stage chronic kidney disease or acute kidney failure. This includes hemodialysis and peritoneal dialysis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Renal Failure","conceptCode":"C4376","definition":"An acute or chronic condition that is characterized by the inability of the kidneys to adequately filter the blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Requirement","conceptCode":"C25652","definition":"Something that is a necessary condition; something that is obligatory.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Dialysis","conceptCode":"C15221","definition":"A procedure to remove toxic substances from the blood that is used in patients with end-stage chronic kidney disease or acute kidney failure. This includes hemodialysis and peritoneal dialysis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F4FE335-DCBF-55FB-E063-731AD00A6D91","latestVersionIndicator":"Yes","beginDate":"2024-01-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-19","modifiedBy":"KUMMEROA","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F4FE335-DCC0-55FB-E063-731AD00A6D91","beginDate":"2024-01-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-19","modifiedBy":"KUMMEROA","dateModified":"2024-01-19","deletedIndicator":"No"},{"value":"Gonadal dysfunction / infertility requiring hormone replacement","valueDescription":null,"ValueMeaning":{"publicId":"14741401","version":"1","preferredName":"Gonadal Disorder And/Or Infertility Requirement Hormone Replacement Therapy","longName":"14741401v1.00","preferredDefinition":"A non-neoplastic or neoplastic disorder that affects the testis or the ovary._Used to indicate that either or both of two items or options may be valid._Inability to conceive for at least one year after trying and having unprotected sex. Causes of female infertility include endometriosis, fallopian tubes obstruction, and polycystic ovary syndrome. Causes of male infertility include abnormal sperm production or function, blockage of the epididymis, blockage of the ejaculatory ducts, hypospadias, exposure to pesticides, and health related issues._Something that is a necessary condition; something that is obligatory._Treatment with estrogens or estrogen/progesterone after menopause or ovariectomy to prevent pathological effects of decreased estrogen production.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gonadal Disorder","conceptCode":"C26786","definition":"A non-neoplastic or neoplastic disorder that affects the testis or the ovary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"And/Or","conceptCode":"C48928","definition":"Used to indicate that either or both of two items or options may be valid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Infertility","conceptCode":"C3836","definition":"Inability to conceive for at least one year after trying and having unprotected sex. Causes of female infertility include endometriosis, fallopian tubes obstruction, and polycystic ovary syndrome. Causes of male infertility include abnormal sperm production or function, blockage of the epididymis, blockage of the ejaculatory ducts, hypospadias, exposure to pesticides, and health related issues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Requirement","conceptCode":"C25652","definition":"Something that is a necessary condition; something that is obligatory.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Hormone Replacement Therapy","conceptCode":"C15599","definition":"Treatment with estrogens or estrogen/progesterone after menopause or ovariectomy to prevent pathological effects of decreased estrogen production.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"10A848C8-7ED4-2010-E063-731AD00AA7AC","latestVersionIndicator":"Yes","beginDate":"2024-02-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-02-05","modifiedBy":"KUMMEROA","dateModified":"2024-02-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"10A848C8-7ED5-2010-E063-731AD00AA7AC","beginDate":"2024-02-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-02-05","modifiedBy":"KUMMEROA","dateModified":"2024-02-05","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"4733404","version":"1","preferredName":"Organ Impairment And/Or Disease or Disorder Type","preferredDefinition":"A unique macroscopic (gross) anatomic structure that performs specific functions.  It is composed of various tissues.  An organ is part of an anatomic system or a body region.  Representative examples include the heart, lung, liver, spleen, and uterus.:Loss or abnormality of psychological, physiological, or anatomic structure or function.:Used to indicate that either or both of two items or options may be valid.:Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.:Something distinguishable as an identifiable class based on common qualities.","longName":"4733404v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Organ","conceptCode":"C13018","definition":"A unique macroscopic (gross) anatomic structure that performs specific functions. It is composed of various tissues.  An organ is part of an anatomic system or a body region. Representative examples include the heart, lung, liver, spleen, and uterus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Impairment","conceptCode":"C21055","definition":"Loss or abnormality of psychological, physiological, or anatomic structure or function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"And/Or","conceptCode":"C48928","definition":"Used to indicate that either or both of two items or options may be valid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"107D438A-B34D-F4E6-E050-BB89AD4319F8","latestVersionIndicator":"Yes","beginDate":"2015-03-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-03-04","modifiedBy":"ONEDATA","dateModified":"2015-03-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2C612778-DA7F-0559-E050-BB89AD430531","latestVersionIndicator":"Yes","beginDate":"2016-02-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-02-22","modifiedBy":"KUMMEROA","dateModified":"2024-02-05","changeDescription":".PVs added for 2540. AK 5/9/18. PVs added for 2100r7. 03/26/2021 KMM. PVs added for 2158r1. 02/08/2022 KMM. PVs added for 2058r1. 02/17/2022 KMM","administrativeNotes":"2024.2.5 PV added per ticket request CADSR0003366. ak 2024.1.19 PVs added per ticket request CADSR0003302. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"HPST_ONPA_noninf_pulm_abn_type","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What is the other non-infecti","type":"Preferred Question Text","description":"What is the other non-infectious pulmonary abnormality?","url":null,"context":"NHLBI"},{"name":"Specify other non-infectious pulmonary abnormality developed","type":"Application Standard Question Text","description":"Specify other non-infectious pulmonary abnormality developed","url":null,"context":"NHLBI"},{"name":"Specify other non-infectious pulmonary abnormality developed","type":"Alternate Question Text","description":"Specify other non-infectious pulmonary abnormality developed","url":null,"context":"NHLBI"},{"name":"Specify other non-infectious pulmonary abnormality developed since the date of last report","type":"Alternate Question Text","description":"Specify other non-infectious pulmonary abnormality developed since the date of last report","url":null,"context":"NHLBI"},{"name":"NMDP Text 1","type":"Alternate Question Text","description":"Specify other non-infectious pulmonary abnormality experienced","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BE739ABF-6F10-4232-E053-4EBD850AA1CD","latestVersionIndicator":"Yes","beginDate":"2021-03-26","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-03-26","modifiedBy":"KUMMEROA","dateModified":"2023-08-08","changeDescription":"Released. 07/27/2021 KMM; System generated def displayed as alt def. ALT name added for 2100r7. 10/04/2021 KMM","administrativeNotes":"2023.8.2 AQT added per ticket request CADSR0002666. ak","unresolvedIssues":null,"deletedIndicator":"No"}}